This is a proposal to renew an ongoing and successful postdoctoral clinical research training program on the human behavioral pharmacology of substance abuse. Ten training positions are proposed, all at the postdoctoral level. Training duration is two years. The goal is to produce experts in various aspects of substance abuse, psychopharmacology, and treatment who go on to succeed as independent clinical researchers, scientists, academicians, and administrators in drug abuse and related fields. Major themes of the research training are: (a) Clinical pharmacology of drug abuse and of medications for treating drug abuse; (b) Behavioral and pharmacological treatments for drug abuse, and their integration; and (c) Psychiatric comorbidity and behavioral assessment of drug abusers. Training consists primarily of conducting supervised clinical research in collaboration with training faculty and analyzing and publishing the results of that research. In addition, trainees present reports at major scientific meetings and participate in an organized program of educational seminars designed to provide both breadth and depth to their knowledge and skills relevant to drug abuse and clinical research. The training program site is a multifaceted drug abuse clinical research program - the Behavioral Pharmacology Research Unit - plus other affiliated drug abuse treatment and research programs at the same campus. Research training will be provided in the following specific areas: clinical pharmacology of drugs of abuse; medications development research; cognitive and behavioral toxicity of drugs of abuse; abuse liability assessment; behavioral treatment of drug abuse; pharmacological treatment of drug abuse; integration of behavioral and pharmacological treatments; psychiatric comorbidity; behavioral assessment; HIV risk behavior assessment; clinical trials research methods and management; addiction and pregnancy; and women?s health issues.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007209-24
Application #
6768726
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
1981-02-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
24
Fiscal Year
2004
Total Cost
$314,138
Indirect Cost
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Getty, Carol-Ann; Subramaniam, Shrinidhi; Holtyn, August F et al. (2018) Evaluation of a Computer-Based Training Program to Teach Adults at Risk for HIV About Pre-Exposure Prophylaxis. AIDS Educ Prev 30:287-300
Davis, Alan K; Arterberry, Brooke J; Bonar, Erin E et al. (2018) Predictors of positive drinking outcomes among youth receiving an alcohol brief intervention in the emergency department. Drug Alcohol Depend 188:102-108
Davis, Alan K; Nickelsen, Tetiana; Zucker, Robert A et al. (2018) Acceptability of nonabstinent treatment outcome goals among addiction treatment providers in Ukraine. Psychol Addict Behav 32:485-495
Nielson, Elizabeth M; May, Darrick G; Forcehimes, Alyssa A et al. (2018) The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions. Front Pharmacol 9:132
Houston, Rebecca J; Schlienz, Nicolas J (2018) Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment. Biol Psychiatry Cogn Neurosci Neuroimaging 3:30-40
Barrett, Frederick S; Carbonaro, Theresa M; Hurwitz, Ethan et al. (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology (Berl) 235:2915-2927
Schlienz, Nicolas J; Lee, Dustin C; Stitzer, Maxine L et al. (2018) The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug Alcohol Depend 187:254-260
Berry, Meredith S; Johnson, Matthew W (2018) Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacol Biochem Behav 164:125-138
Tompkins, D Andrew; Huhn, Andrew S; Johnson, Patrick S et al. (2018) To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients. Addiction 113:67-79
Schlienz, Nicolas J; Cone, Edward J; Herrmann, Evan S et al. (2018) Pharmacokinetic Characterization of 11-nor-9-carboxy-?9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults. J Anal Toxicol 42:232-247

Showing the most recent 10 out of 288 publications